Header Logo

Connection

VICTOR RIVERA to Skin

Back to Details
This is a "connection" page, showing publications VICTOR RIVERA has written about Skin.
VICTOR RIVERA
Connection Strength
0.086
Skin
  1. Analysis of the pharmacodynamic activity of the mTOR inhibitor ridaforolimus (AP23573, MK-8669) in a phase 1 clinical trial. Cancer Chemother Pharmacol. 2012 May; 69(5):1369-77.
    View in: PubMed
    Score: 0.070
  2. Phase IB study of the mTOR inhibitor ridaforolimus with capecitabine. J Clin Oncol. 2010 Oct 20; 28(30):4554-61.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.